Meeting with Angels and Others
A lot of what we do has to do with timing and coordination. Different types of investors are best brought into play at different times and under different Read more
May 20
Natural Conclusions
I certainly don’t want to overstate the case, but there is a profound way that biotechnology makes therapies and cures happen by tapping into the nature of how things are. It’s hard to say that in any other way. Read more
The Value of Focus
It would be hard to argue with the observation that the amount of information in technical areas is exploding. This was true before we had the internet; nowadays, growth is nearly exponential. Add to that the nature of biotechnology, a rapidly evolving science, and it becomes clear why the earliest lesson we learned was this: focus, focus, focus. Read more
Innovative Due Diligence
If you’ve been doing something for twenty years and your goal is to keep doing it better, you can’t avoid looking back at your experience and deriving from it a set of principles. This is especially true if the venture is new at the outset, largely untested by anyone, which is how I found the field of biotechnology investing. Read more
Dr. Lindsay Rosenwald: The FDA Development and Approval Process
Currently serving as a co-founder and partner of Opus Point Partners, Dr. Lindsay Rosenwald has fostered the growth of several important drugs, including the cancer-treating compounds arsenic trioxide and abiraterone. New drugs, however, must first pass
Dr. Lindsay Rosenwald and Arsenic Trioxide
Over the course of his career as an asset manager and investor in the field of healthcare, Dr. Lindsay Rosenwald has helped several pharmaceutical research companies develop new drugs and bring them to market. In particular, Dr. Rosenwald played an important Read more
